Biotech stocks are rallying as clinical wins, M&A and new drug technologies revive the sector. Here are the ETFs and stocks analysts favor.
Biotech stocks are surging. How investors can play the new drug innovation boom
Trending
- What’s The Difference Between C.A.R.B. Compliant Car Parts Vs. Ones That California Bans?
- 23 dazzling panoramic images from the 2026 Epson International Pano Awards
- Elden Ring movie has a budget of nearly $200 million
- Murder in Malaysia’s Beverly Hills | True Crime Reports
- Thousands mourn victims of deadly Jordan church attack
- UN official warns AI could ‘deepen’ global inequality
- Seven killed in Gaza as Israel targets university campus and other sites
- Venezuelan opposition leader María Machado returns after months in exile